Biotech2 years ago
Oryzon Cuts Losses by 20.7%, Faes Farma Earns almost 92 Million in 2023
Oryzon Genomics reduces losses by 20.7% in 2023, reporting over 3.3 million euros compared to the previous year's 4.2 million. Income falls by nearly 28%, standing...